Kala Pharmaceuticals, Inc. Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kala Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kala Pharmaceuticals, Inc. for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Grant | A | 0.00 | 16,000 | 0 | 64,293 | 48.3 K to 64.3 K (+33.13 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Grant | A | 0.00 | 20,000 | 0 | 24,824 | 4.8 K to 24.8 K (+414.59 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Iwicki Mark T | Chief Executive Off ... | Grant | A | 0.00 | 49,560 | 0 | 49,560 | 0 to 49.6 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Paull Robert Bradley | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Trachtenberg Eric | See Remarks | Grant | A | 0.00 | 16,000 | 0 | 44,901 | 28.9 K to 44.9 K (+55.36 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Option Exercise | M | 0.47 | 1,944 | 914 | 0 | |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Option Exercise | M | 0.68 | 2,880 | 1,958 | 0 | |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Buy | M | 0.47 | 1,944 | 914 | 4,824 | 2.9 K to 4.8 K (+67.50 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Buy | M | 0.68 | 2,880 | 1,958 | 2,880 | 0 to 2.9 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Paull Robert Bradley | Director | Buy | J | 0.00 | 1,287 | 0 | 2,361 | 1.1 K to 2.4 K (+119.83 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Paull Robert Bradley | Director | Buy | J | 0.00 | 477 | 0 | 1,074 | 597 to 1.1 K (+79.90 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Paull Robert Bradley | Director | Buy | J | 0.00 | 597 | 0 | 597 | 0 to 597 |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Grunberg Gregory | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Brazzell Romulus K | Chief Medical Offic ... | Grant | A | 0.00 | 19,000 | 0 | 195,496 | 176.5 K to 195.5 K (+10.77 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | KOVEN ANDREW I | Director | Grant | A | 0.00 | 28,000 | 0 | 28,000 | 0 to 28 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Chen Hongming | Chief Scientific Of ... | Grant | A | 0.00 | 16,000 | 0 | 102,849 | 86.8 K to 102.8 K (+18.42 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Grant | A | 0.00 | 19,000 | 0 | 29,000 | 10 K to 29 K (+190.00 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Trachtenberg Eric | See Remarks | Grant | A | 0.00 | 16,000 | 0 | 44,901 | 28.9 K to 44.9 K (+55.36 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Option Exercise | M | 0.47 | 1,944 | 914 | 0 | |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Option Exercise | M | 0.68 | 2,880 | 1,958 | 0 | |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Buy | M | 0.47 | 1,944 | 914 | 4,824 | 2.9 K to 4.8 K (+67.50 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Rosen Howard B | Director | Buy | M | 0.68 | 2,880 | 1,958 | 2,880 | 0 to 2.9 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Paull Robert Bradley | Director | Buy | J | 0.00 | 1,287 | 0 | 2,361 | 1.1 K to 2.4 K (+119.83 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Paull Robert Bradley | Director | Buy | J | 0.00 | 477 | 0 | 1,074 | 597 to 1.1 K (+79.90 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Paull Robert Bradley | Director | Buy | J | 0.00 | 597 | 0 | 597 | 0 to 597 |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Grunberg Gregory | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Brazzell Romulus K | Chief Medical Offic ... | Grant | A | 0.00 | 19,000 | 0 | 195,496 | 176.5 K to 195.5 K (+10.77 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | KOVEN ANDREW I | Director | Grant | A | 0.00 | 28,000 | 0 | 28,000 | 0 to 28 K |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Chen Hongming | Chief Scientific Of ... | Grant | A | 0.00 | 16,000 | 0 | 102,849 | 86.8 K to 102.8 K (+18.42 %) |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Grant | A | 0.00 | 19,000 | 0 | 29,000 | 10 K to 29 K (+190.00 %) |
| Jun 22 2020 | KALA | Kala Pharmaceutica ... | Trachtenberg Eric | See Remarks | Option Exercise | M | 5.19 | 28,901 | 149,996 | 136,099 | |
| Jun 22 2020 | KALA | Kala Pharmaceutica ... | Trachtenberg Eric | See Remarks | Buy | M | 5.19 | 28,901 | 149,996 | 28,901 | 0 to 28.9 K |
| Jun 11 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Option Exercise | M | 2.30 | 11,520 | 26,496 | 0 | |
| Jun 11 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Option Exercise | M | 2.30 | 15,360 | 35,328 | 0 | |
| Jun 11 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Option Exercise | M | 5.21 | 5,077 | 26,451 | 0 | |
| Jun 11 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Option Exercise | M | 2.30 | 11,520 | 26,496 | 0 | |
| Jun 11 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Buy | M | 2.30 | 11,520 | 26,496 | 48,293 | 36.8 K to 48.3 K (+31.33 %) |
| Jun 11 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Buy | M | 2.30 | 15,360 | 35,328 | 36,773 | 21.4 K to 36.8 K (+71.73 %) |
| Jun 11 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Buy | M | 5.21 | 5,077 | 26,451 | 21,413 | 16.3 K to 21.4 K (+31.08 %) |
| Jun 11 2020 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Buy | M | 2.30 | 11,520 | 26,496 | 16,336 | 4.8 K to 16.3 K (+239.20 %) |